Skip to main content

Theranostics, Gallium-68, and Other Radionuclides

A Pathway to Personalized Diagnosis and Treatment

  • Conference proceedings
  • © 2013

Overview

  • Examines in detail the latest developments in theranostics for neuroendocrine tumors and other diseases
  • Covers a wide spectrum of topics, from radiochemistry to clinical applications
  • Focuses on gallium-68 but also considers other PET radionuclides
  • Includes supplementary material: sn.pub/extras

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 194)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (34 papers)

  1. Radiochemistry and Radiopharmacy

  2. Molecular Imaging Using 68Ga labeled Tracers

Keywords

About this book

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics – the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly. The focus of this book is on the rapidly developing research into and clinical applications of gallium-68 and other generator-produced PET radionuclides in the personalized diagnosis and treatment of neuroendocrine tumors and other diseases. In addition, new PET radiopharmaceuticals are considered, and the latest ideas and concepts, presented. Theranostics embodies both molecular and personalized medicine. It is at the cutting edge of medicine, and the contents of this volume will be of interest to chemists, physicians, and investigators dealing with generators, PET radiochemistry, molecular imaging, and radionuclide therapy.

Reviews

From the reviews:

“The general themes of this book (theranostics and peptide receptor–targeted radiotherapy) derive from evolving successes in the use of generator-produced 68Ga for molecular imaging of disease. … This book is an excellent resource for investigators interested in gaining a detailed understanding of the state of the art in 68Ga and peptide receptor radionuclide therapy–based theranostics for preclinical and emerging clinical applications.” (Michael K. Schultz, The Journal of Nuclear Medicine, Vol. 54 (4), April, 2013)

Editors and Affiliations

  • , THERANOSTICS Center for Molecular,, ENETS Center of Excellence, Bad Berka, Germany

    Richard P. Baum

  • Inst. Kernchemie, Universität Mainz, Mainz, Germany

    Frank Rösch

Bibliographic Information

  • Book Title: Theranostics, Gallium-68, and Other Radionuclides

  • Book Subtitle: A Pathway to Personalized Diagnosis and Treatment

  • Editors: Richard P. Baum, Frank Rösch

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-27994-2

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2013

  • Hardcover ISBN: 978-3-642-27993-5Published: 23 August 2012

  • Softcover ISBN: 978-3-642-44160-8Published: 20 September 2014

  • eBook ISBN: 978-3-642-27994-2Published: 23 August 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XVIII, 578

  • Topics: Oncology, Nuclear Medicine, Neuroradiology, Radiotherapy, Molecular Medicine

Publish with us